Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.

On February 4, 2020, the U.S. Department of Health and Human Services, which already worked with Regeneron, announced that Regeneron would pursue monoclonal antibodies to fight COVID-19.

Regeneron is a leading biotechnology company dedicated to inventing, developing and commercializing life-transforming medicines for people with serious diseases.

Get real-time Regeneron Pharmaceuticals, Inc. (REGN) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on …

Nov 5, 2025 · Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases.

We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center® (RGC) and pioneering genetic medicine platforms, enabling us to identify innovative targets …

Find addresses and contact information for Regeneron offices worldwide with locations across North America, Europe and Asia.

Discover insights into Regeneron's stock information and other key information relevant for investors.

Explore Regeneron’s research and advancements in oncology and hematology.

At Regeneron, our goal is to address serious medical conditions across multiple and diverse therapeutic areas. Our 14 medicines approved in the U.S. or other countries are only the beginning of our long …